BMD's (BioMedical Diagnostics) automated sample preparation tech:
This article was originally published in Clinica
French firm BMD (BioMedical Diagnostics) has CE-marked for sale in Europe an automated module for preparing test samples for autoimmune disease diagnosis. Called Caris (carrier for assay reagents and immuno samples), the module has been incorporated into the firm's high throughput diagnostic system, Fidis FPX. Caris fully automates the preparation process including sample identification, dilution, dispensing and wash steps. Users merely insert the reaction plate into the Fidis system to begin high throughput analysis of the samples, said the Marne-la-Vallee, greater Paris firm.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.